Biote Corp BTMD
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BTMD is a good fit for your portfolio.
News
-
Biote Schedules First Quarter 2024 Financial Results Release and Conference Call
-
Biote Reports Fourth Quarter and Full Year 2023 Financial Results
-
Biote Schedules Fourth Quarter and Full Year 2023 Financial Results Release and Conference Call
-
Biote Announces Agreement to Resolve Litigation and Repurchase All of Founder’s Shares
Trading Information
- Previous Close Price
- $5.58
- Day Range
- $5.40–5.73
- 52-Week Range
- $3.67–8.22
- Bid/Ask
- $5.50 / $5.51
- Market Cap
- $199.91 Mil
- Volume/Avg
- 68,915 / 119,493
Key Statistics
- Price/Earnings (Normalized)
- 4.17
- Price/Sales
- 0.77
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Stock Style Box
- Small Value
- Total Number of Employees
- 194
- Website
- https://www.biote.com
Comparables
Valuation
Metric
|
BTMD
|
NORDH
|
CMAX
|
---|---|---|---|
Price/Earnings (Normalized) | 4.17 | — | — |
Price/Book Value | — | 2.87 | 0.19 |
Price/Sales | 0.77 | 6.42 | 0.02 |
Price/Cash Flow | 3.96 | 7,619.99 | — |
Price/Earnings
BTMD
NORDH
CMAX
Financial Strength
Metric
|
BTMD
|
NORDH
|
CMAX
|
---|---|---|---|
Quick Ratio | 4.37 | 3.05 | 0.41 |
Current Ratio | 5.51 | 3.14 | 0.42 |
Interest Coverage | 0.98 | −1,368.75 | −11.57 |
Quick Ratio
BTMD
NORDH
CMAX
Profitability
Metric
|
BTMD
|
NORDH
|
CMAX
|
---|---|---|---|
Return on Assets (Normalized) | 16.91% | −11.20% | −14.63% |
Return on Equity (Normalized) | — | −12.74% | −31.50% |
Return on Invested Capital (Normalized) | 48.82% | −11.92% | −10.43% |
Return on Assets
BTMD
NORDH
CMAX
Medical Care Facilities Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
HCA
| HCA Healthcare Inc | Tkqjzvyc | Nypgmc | $83.1 Bil | |
FSNUY
| Fresenius SE & Co KGaA ADR | — | Hqgqhg | $16.4 Bil | |
FSNUF
| Fresenius SE & Co KGaA | — | Sspcrg | $16.4 Bil | |
BDUUY
| Bangkok Dusit Medical Services PCL ADR | — | Mws | $12.3 Bil | |
FMCQF
| Fresenius Medical Care AG | — | Zlycgpg | $11.9 Bil | |
FMS
| Fresenius Medical Care AG ADR | Prcnb | Pxxps | $11.9 Bil | |
DVA
| DaVita Inc | Myzzzwyjl | Fgnkzs | $11.7 Bil | |
UHS
| Universal Health Services Inc Class B | — | Zscplh | $11.2 Bil | |
THC
| Tenet Healthcare Corp | Pwprwxw | Cttc | $9.5 Bil | |
AMN
| AMN Healthcare Services Inc | Wjjjkjfc | Yygmy | $2.2 Bil |